NRX Pharmaceuticals, Inc (NRXP): 25-NSE filed May 22, 2026

Form type
25-NSE
Filing date
May 22, 2026
Accession number
0001354457-26-000493
Filer
NRX Pharmaceuticals, Inc (CIK 1719406)